Search - tctmd.com

Displaying 901 - 920 of 1024

Sort: Relevancy | Date

Presentation TCT 2013

Case #10: We Will Start Using Dedicated Bifurcation Devices!

Presenter: Niels Holm

October 30, 2013

Presentation TCT 2013

Build Future Bifurcation Strategies on Present Evidence

Presenter: Miroslaw Ferenc

October 30, 2013

Presentation TCT 2013

BVS in Bifurcations: One and Two Stent Options (With Case Examples)

Presenter: Vladimir Dzavik

October 30, 2013

News Conference News TCT 2013

Two Studies Examine Two-Stent Strategy vs. Provisional Stenting in Coronary Bifurcation Lesions

October 30, 2013

News Conference News TCT 2013

Innovation in Intervention: Perspectives from Industry

October 30, 2013

Presentation TCT 2013

TCT-25. Five-year clinical follow-up of unprotected left main bifurcation lesion stenting: one- versus two-stent techniques versus double-kissing crush technique

Presenter: Yao-Jun Zhang

October 29, 2013

Presentation TCT 2013

Case Presentation 3: Primary PCI with a Complex Bifurcation of the Left Main

Presenter: Miroslav Vytiska

October 29, 2013

Presentation TCT 2013

Bifurcation Strategies with the Absorb BVS Everolimus-Eluting Resorbable Scaffold: A Bench Study

Presenter: JM White

October 29, 2013

Presentation TCT 2013

To cover or not to cover deep femoral arteries in stenting for bifurcation lesions of superficial femoral artery

Presenter: Sung-Jin Hong

October 29, 2013

Presentation TCT 2013

TCT-33. Bioresorbable Vascular Scaffold Use in Coronary Bifurcation Lesions

Presenter: Toru Naganuma

October 29, 2013

Presentation TCT 2013

TCT-29. First-in-Man Study of Dedicated Bifurcation Sirolimus-Eluting Stent BiOSS LIM

Presenter: Robert Gil

October 29, 2013

Presentation TCT 2013

TCT-26. Randomized Comparison Of Final Kissing Balloon Dilatation Versus No Final Kissing Balloon Dilatation In Patients With Coronary Bifurcation Lesions Treated With Main Vess...

Presenter: Niels Holm

October 29, 2013

Presentation TCT 2013

TCT-22. The STENTYS Self-Expanding Drug-Eluting Stent in Coronary Bifurcation Lesions at 6 Months Follow-up : Results from the OPEN II Trial

Presenter: Christoph Naber

October 29, 2013

Presentation TCT 2013

Meta-analysis of Long Term Outcomes of Intravascular Ultrasound versus Angiographic-Guided Percutaneous Coronary Intervention of Bifurcation Lesions

Presenter: VG Patel

October 29, 2013

Presentation TCT 2013

Essential Strategies to Optimize Left Main and Non-Left Main Bifurcation Stenting

Presenter: Leif Thuesen

October 29, 2013

Presentation TCT 2013

Two Complex Left Main Bifurcation Cases

Presenter: Antonio Colombo

October 28, 2013

Presentation TCT 2013

Treatment of Coronary Bifurcation Lesions with a Self-Expanding DES: 6-Month Results from the OPEN II Trial

Presenter: Christoph Naber

October 28, 2013

Presentation TCT 2013

Bioresorbable Scaffolds in Bifurcation Applications: Technique Considerations and outcomes

Presenter: Vladimir Dzavik

October 28, 2013

Presentation TCT 2013

Bifurcation Treatment with a Drug-Coated Balloon for the Sidebranch and DES for the Main Branch DES: The BIOLUX I Trial

Presenter: Stephen Worthley

October 28, 2013

Presentation TCT 2013

Are There Meaningful Clinical Differences between Different DES in Left Main Bifurcation and Non-bifurcation Lesions? The ISAR Left Main Trials and Other Data

Presenter: Adnan Kastrati

October 28, 2013

Advertisement

Case #10: We Will Start Using Dedicated Bifurcation Devices!

Build Future Bifurcation Strategies on Present Evidence

BVS in Bifurcations: One and Two Stent Options (With Case Examples)

Two Studies Examine Two-Stent Strategy vs. Provisional Stenting in Coronary Bifurcation Lesions

Innovation in Intervention: Perspectives from Industry

TCT-25. Five-year clinical follow-up of unprotected left main bifurcation lesion stenting: one- versus two-stent techniques versus double-kissing crush technique

Case Presentation 3: Primary PCI with a Complex Bifurcation of the Left Main

Bifurcation Strategies with the Absorb BVS Everolimus-Eluting Resorbable Scaffold: A Bench Study

To cover or not to cover deep femoral arteries in stenting for bifurcation lesions of superficial femoral artery

TCT-33. Bioresorbable Vascular Scaffold Use in Coronary Bifurcation Lesions

TCT-29. First-in-Man Study of Dedicated Bifurcation Sirolimus-Eluting Stent BiOSS LIM

TCT-26. Randomized Comparison Of Final Kissing Balloon Dilatation Versus No Final Kissing Balloon Dilatation In Patients With Coronary Bifurcation Lesions Treated With Main Vess...

TCT-22. The STENTYS Self-Expanding Drug-Eluting Stent in Coronary Bifurcation Lesions at 6 Months Follow-up : Results from the OPEN II Trial

Meta-analysis of Long Term Outcomes of Intravascular Ultrasound versus Angiographic-Guided Percutaneous Coronary Intervention of Bifurcation Lesions

Essential Strategies to Optimize Left Main and Non-Left Main Bifurcation Stenting

Two Complex Left Main Bifurcation Cases

Treatment of Coronary Bifurcation Lesions with a Self-Expanding DES: 6-Month Results from the OPEN II Trial

Bioresorbable Scaffolds in Bifurcation Applications: Technique Considerations and outcomes

Bifurcation Treatment with a Drug-Coated Balloon for the Sidebranch and DES for the Main Branch DES: The BIOLUX I Trial

Are There Meaningful Clinical Differences between Different DES in Left Main Bifurcation and Non-bifurcation Lesions? The ISAR Left Main Trials and Other Data

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content